Evidence supporting somatic KLLN deletions have also been observed in 21% of breast carcinomas in The Cancer Genome Atlas (TCGA) and there has been an established association between increased tumor grade and decreased KLLN expression in breast carcinomas versus adjacent normal tissue [6, 9]. The gene discussed is KLLN; the disease is breast carcinoma.